Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph Buchert

Showing results (21-30 of 179) with videos related to

Pageof 18
Sort By:
Progress in Neurobiology|May 24, 2011
Development of Alzheimer-disease neuroimaging-biomarkers using mouse models with amyloid-precursor protein-transgene expressionStefan J Teipel, Ralph Buchert, Johannes Thome, et al.
BMJ Case Reports|July 26, 2017
Awakening with amantadine from a persistent vegetative state after subarachnoid haemorrhageSophie Mirabell Lehnerer, Franziska Scheibe, Ralph Buchert, et al.
Neuropsychobiology|January 11, 2022
Extrastriatal Dopamine D2/3 Receptor Availability in Alcohol Use Disorder and Individuals at High RiskGianna Spitta, Tobias Gleich, Kristin Zacharias, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|February 27, 2010
Identification of transport processes in bioirrigated muddy sediments by [18F]fluoride PET (Positron Emission Tomography)Andrea Roskosch, Jörg Lewandowski, Ralf Bergmann, et al.
Neuroimage|January 1, 2017
PETPVE12: an SPM toolbox for Partial Volume Effects correction in brain PET - Application to amyloid imaging with AV45-PETGabriel Gonzalez-Escamilla, Catharina Lange, Stefan Teipel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 26, 2024
Incorporating label uncertainty during the training of convolutional neural networks improves performance for the discrimination between certain and inconclusive cases in dopamine transporter SPECTAleksej Kucerenko, Thomas Buddenkotte, Ivayla Apostolova, et al.
Journal of Alzheimer'S Disease : JAD|September 14, 2020
Brain FDG PET for the Etiological Diagnosis of Clinically Uncertain Cognitive Impairment During Delirium in RemissionFranziska Mathies, Catharina Lange, Anja Mäurer, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|April 19, 2011
Pulmonary FDG uptake without a CT counterpart - a pitfall in interpreting PET/CT imagesNils Schreiter, Munenobu Nogami, Ralph Buchert, et al.
Orphanet Journal of Rare Diseases|March 6, 2022
White matter is increased in the brains of adults with neurofibromatosis 1Su Wang, Jan M Friedman, Per Suppa, et al.
Nuklearmedizin. Nuclear Medicine|April 15, 2025
The Status of Neuroimaging with SPECT and PET in Germany: Results from the 1st Survey on Nuclear Neuroimaging in Germany in 2023Ralph Buchert, Alexander Drzezga, Mathias Schreckenberger, et al.
Pageof 18

Showing results (21-30 of 179) with videos related to

Sort By:
Pageof 18
Progress in Neurobiology|May 24, 2011
Development of Alzheimer-disease neuroimaging-biomarkers using mouse models with amyloid-precursor protein-transgene expressionStefan J Teipel, Ralph Buchert, Johannes Thome, et al.
BMJ Case Reports|July 26, 2017
Awakening with amantadine from a persistent vegetative state after subarachnoid haemorrhageSophie Mirabell Lehnerer, Franziska Scheibe, Ralph Buchert, et al.
Neuropsychobiology|January 11, 2022
Extrastriatal Dopamine D2/3 Receptor Availability in Alcohol Use Disorder and Individuals at High RiskGianna Spitta, Tobias Gleich, Kristin Zacharias, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|February 27, 2010
Identification of transport processes in bioirrigated muddy sediments by [18F]fluoride PET (Positron Emission Tomography)Andrea Roskosch, Jörg Lewandowski, Ralf Bergmann, et al.
Neuroimage|January 1, 2017
PETPVE12: an SPM toolbox for Partial Volume Effects correction in brain PET - Application to amyloid imaging with AV45-PETGabriel Gonzalez-Escamilla, Catharina Lange, Stefan Teipel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 26, 2024
Incorporating label uncertainty during the training of convolutional neural networks improves performance for the discrimination between certain and inconclusive cases in dopamine transporter SPECTAleksej Kucerenko, Thomas Buddenkotte, Ivayla Apostolova, et al.
Journal of Alzheimer'S Disease : JAD|September 14, 2020
Brain FDG PET for the Etiological Diagnosis of Clinically Uncertain Cognitive Impairment During Delirium in RemissionFranziska Mathies, Catharina Lange, Anja Mäurer, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|April 19, 2011
Pulmonary FDG uptake without a CT counterpart - a pitfall in interpreting PET/CT imagesNils Schreiter, Munenobu Nogami, Ralph Buchert, et al.
Orphanet Journal of Rare Diseases|March 6, 2022
White matter is increased in the brains of adults with neurofibromatosis 1Su Wang, Jan M Friedman, Per Suppa, et al.
Nuklearmedizin. Nuclear Medicine|April 15, 2025
The Status of Neuroimaging with SPECT and PET in Germany: Results from the 1st Survey on Nuclear Neuroimaging in Germany in 2023Ralph Buchert, Alexander Drzezga, Mathias Schreckenberger, et al.
Pageof 18